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Background: Modular polyketide synthases (PKSs) catalyse the biosynthesis of 
complex polyketides using a different set of enzymes for each successive cycle of 
chain extension. Directed biosynthesis starting from synthetic diketides is a 
potentially valuable route to novel polyketides. We have used a purified bimodular 
derivative of the erythromycin-producing polyketide synthase (DEBS 1 -TE) to 
study chain extension starting from a variety of diketide analogues and, in some 
cases, from the alternative acyl-CoA thioester substrates. 
Results: Chain initiation in vitro by DEBS 1 -TE module 2 using a synthetic 
diketide analogue as a substrate was tolerant of significant structural variation in 
the starter unit of the synthetic diketide, but other changes completely abolished 
activity. Interestingly, a racemic p-keto diketide was found to be reduced in situ on 
the PKS and utilised in place of its more complex hydroxy analogue as a substrate 
for chain extension. The presence of a diketide analogue strongly inhibited chain 
initiation via the loading module. Significantly higher concentrations of diketide 
N-acetylcysteamine analogues than their corresponding acyl-CoA thioesters are 
required to achieve comparable yields of triketide lactones. 
Conclusions: Although a broad range of variation in the starter residue is 
acceptable, the substrate specificity of module 2 of a typical modular PKS in vitro 
is relatively intolerant of changes at C-2 and C-3. This will restrict the usefulness 
of approaches to synthesise novel erythromycins using synthetic diketides in ho. 
The use of synthetic p-keto diketides in viva deserves to be explored. 
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Introduction 
Complex or reduced polyketides, such as the antibacterial 
erythromycin A, constitute a large and structurally diverse 
class of natural products generated mainly by Streptumyces 
and related filamentous bacteria. They are derived from 
simple carboxylic acid precursors by stepwise chain assem- 
bly on modular polyketide synthases (PKSs). PKSs are giant 
multienzyme complexes [l-8] that contain a different set or 
module of enzyme domains to accomplish each successive 
cycle of chain extension; for example, 6-deoxyerythronolide 
B synthase (DEBS), responsible for the biosynthesis of the 
aglycone core of erythromycin A (l), contains six such 
modules housed in three large polypeptides, DEBS 1, 
DEBS 2 and DEBS 3 (Figure la) [9]. Because of the 
modular nature of these synthases, considerable attention 
has focused on the possibility of generating novel antibiotics 
through combinatorial manipulation of the genes for their 
constituent domains [lO-131. The diversity of such combi- 
natorial libraries can be specifically enhanced by altering 
the chain initiation process to accept a broad range of alter- 
native starter units [14-161. A complementary approach to 
altering the chain initiation step [17] follows from early 
experiments in which synthetic analogues of putative inter- 
mediates, particularly diketides as their N-acetylcysteamine 
(NAC) thioesters, were shown to be successfully incorpo- 
rated into macrocyclic polyketides [ 18-221. 
There are many factors that together determine the effi- 
ciency with which a synthetic substrate analogue can be 
utilised by a polyketide synthase in Go, including cell per- 
meability, toxicity to the cell, susceptibility to B-oxidatim 
or other types of degradation, a requirement for derivatisa- 
tion to an active species such as a CoA-thioester and the 
specificity of the PKS to which it is directed. It is therefore 
of great interest to obtain a clearer idea of the potential for 
precursor-directed biosynthesis, using purified enzymes in 
vitro. In earlier in vitro experiments to study the loading of 
diketides at the module 2 ketosynthase domain (KS2) 
[23,24], Chuck et aL. [24] relied on their bimodular deriva- 
tive of DEBS (DEBS 1 +TE) [25] that catalyses the for- 
mation of triketide lactone 2 from one equivalent of a 
starter CoA-thioester (normally propionyl-CoA) and two 
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Figure 1 
(a) DEBS 1 -DEBS2- -DEBS3- 
(a) Organisation of the 6-deoxyerythronolide 
Load Module 4 Module 6 B synthase (DEBS). The DEBS system is 
- Module 1 - Module 3 Module 5 End composed of three bimodular polypeptides, 
DEBS 1, DEBS 2 and DEBS 3, that co- 
operate to form the erythromycin aglycone, 
6-deoxyerythronolide B 1. DEBS 1 -TE, a 
truncated form of the polyketide synthase 
(PKS) created by adding a copy of the 
terminal thioesterase domain to the end of 
DEBS 1, produces the triketide lactone, 
(2R,-3S, 4R, 5R)-3, 5-dihydroxy-2, 4-dimethyl- 
n-heptanoic acid S-lactone 2. Incorporation of 
a synthetic diketide intermediate, derivatised 
as its N-acetylcysteamine (NAC) thioester 3, 
has been shown to occur at the ketosynthase 
domain of module 2. (b) Structural analysis of 
the natural diketide intermediate formed by 
condensation of propionyl-CoA and 
(2s)methylmalonyl-CoA. The acyl-terminal 
portion (shown in red) is determined by the 
choice of starter unit, whereas the structure 
shown in blue, which includes the functionality 
2 at C-2, and the stereochemistry about the 
C-2, C-3 bond, is established during chain 
extension. Both portions of the diketide were 
0-d varied in designing our synthetic analogues. 
1 
8 QH 
AT, acyltransferase; ACP, acyl carrier protein; 
KR, P-ketoacyl reductase; KS, P-ketoacyl 
synthase; ER, enoyl reductase; TE, 
thioesterase. 
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equivalents of chain-extending (ZS)-methylmalonyl-CoA 
[26] (Figure la). More specifically, they used a version of 
this protein in which the KS1 domain was inactivated to 
suppress its reported methylmalonyl-CoA decarboxylase 
activity [27,28]. 
In the present investigation we have used a similar bimod- 
ular PKS, DEBS l-TE [29], in which we have shown pre- 
viously that DEBS 1-catalysed decarboxylation does not 
occur to any detectable extent [30]. Using our system we 
have comprehensively explored the potential for stereo- 
chemical variation in module 1 by evaluating diketide ana- 
logues in which the stereochemistry at either or both of 
the C-Z and C-3 centres has been altered. We have also 
addressed the feasibility of increasing the steric bulk of 
the branching sidechain. We have further investigated the 
potential for structural variation in the starter acid residue, 
and have carried out complementary studies to compare 
chain initiation from the equivalent starter CoA deriva- 
tives. Finally, we have evaluated the practicality of using 
synthetically more accessible racemic B-keto diketides in 
place of their corresponding B-hydroxy analogues. 
Results and discussion 
Design of diketide analogues 
In the normal course of erythromycin biosynthesis, a 
diketide intermediate is formed by the condensation of a 
propionyl-CoA starter unit with one equivalent of chain- 
extending (ZS)-methylmalonyl-CoA [26]. Diketide struc- 
ture can, therefore, be considered in two parts: the chain 
extension structure including the functionality at C-Z and 
the stereochemistry, if any, about the C-2, C-3 bond 
(Figure lb), and the functionality at the acyl terminus 
(determined by the choice of starter unit). 
Structural variation in the chain extension unit: C-2, C-3 
stereochemistry 
The feasibility of altering the stereochemistry of chain 
extension in module 1 was assessed by feeding analogues 
4-6 (Figure Z), which exhibit, respectively, all three non- 
natural C-2, C-3 configurations (in previous work, com- 
pound 5 failed to become incorporated into triketide 
lactone [24]). Syntheses of diketide analogues, with the 
exception of 3b and 14-16 given here (see the Materials 
and methods section), have been published previously [31]. 
Structural variation in the chain extension unit: C-2 alkyl 
substituent 
In a previous study, Chuck etal. [24] reported the incor- 
poration of (3R)-3-hydroxypentanoic acid NAC, a dike- 
tide analogue lacking a methyl group at the C-Z position; 
such an intermediate would arise by chain extension 
from malonyl-CoA. In this study, the sterically more 
demanding C-Z ethyl group was instead introduced into 
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Figure 2 
Diketide 3 is the N-acetylcysteamine thioester 
of the natural intermediate in the biosynthesis 
of the triketide lactone 2 by DEBS 1 -TE and 
6-deoxyerythronolide B 1 by the complete 
DEBS. Diketides 4-16 are synthetic 
analogues of 3, which incorporate variations in 
functionality, stereochemistry, and level of 
P-keto reduction. Compounds 17-27 are the 
lactone products expected upon successful 
processing of these ‘unnatural’ diketides by 
DEBS 1 -TE. A check mark indicates that the 
triketide lactone product was observed by 
GC-MS and/or radiochemical TLC. 
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analogues 7 and 8 to model chain extension by ethyl- 
malonyl-CoA. 
Structural variation in the starter unit 
To evaluate the potential for using synthetic diketide ana- 
logues as a means of altering the starter unit residue of 
polyketides, we prepared the three compounds %ll (and 
12; Figure 2) that correspond to the incorporation of 
acetyl-CoA, n-butyryl-CoA and iso-butyryl-CoA, respec- 
tively, but maintain the natural C-2, C-3 stereochemistry 
of the diketide intermediate. These three non-natural 
starter units have been shown previously to incorporate 
into triketide lactones [32-341. Analogues 13 and 14, cor- 
responding to processing of benzoyl-CoA and cyclohexyl- 
CoA, respectively, were also investigated. 
Incorporation of B-keto diketides 
We also examined the processing of the racemic P-keto 
analogues 15 and 16 (for synthesis, see Figure 3 and the 
Materials and methods section) to triketides; these com- 
pounds also contained the unnatural starter units acetyl- 
CoA and iso-butyryl-CoA, respectively. Two alternative 
outcomes were envisaged for these substrates: the keto 
groups at C-3 would be stereoselectively reduced by the 
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Synthesis of racemic 5-keto diketide NAC analogues 15 and 16. 
For experimental details, see the Materials and methods section. 
Reagents and conditions: (8 1.2 equivalents LDA, THF, -78’C, 2 h; 
1.2 equivalents MgBr, l OEt, in Et,O, -78°C-+O“C, 2 min, then 
O“C+-78’C, 2 min; 1.3 equivalents acetyl chloride, -78°C 30 min; 
(ii) 2 equivalents LiN(SiMe,),, 1.2 equivalents NAC, THF, -78°C 
15 min, then 0°C 45 min. (iii) 1.2 equivalents LDA, THF, -78%, 
2 h; 1.2 equivalents MgBr, l OEt, in Et,O, -78°C+00C, 2 min, 
then O°C+-780C, 2 min; 1.3 equivalents iso-butyryl chloride, 
-78’C, 30 min. 
ketoreductase domains of module 1 (KRl) and module 2 
(KRZ). Reduction of the natural P-keto diketide analogue 
as its NAC thioester has been shown to occur without 
loading onto the PKS (I.E. Holzbaur, personal communi- 
cation). The resulting P-hydroxy diketides could then be 
accepted by KS2 for chain extension to the triketide, or 
the unreduced racemic analogues would load directly onto 
KSZ. Processing in module 2 would produce triketides 
lacking the terminal hydroxyl group necessary for lactoni- 
sation, and so presumably the chains would be released 
from the thioesterase as free acids [35]. If the former 
outcome were observed, ketoreductase-catalysed reduc- 
tions could be exploited as a general means of establishing 
the stereochemistry of synthetic diketides, greatly simpli- 
fying the preparation of these analogues. 
Choice of analytical methods 
In earlier work with diketides, analysis by radiochemical 
thin layer chromatography (TLC) and comparison to syn- 
thetic standards proved adequate for most substrates 
[24]. The resolution provided by TLC, however, proved 
inadequate for the much wider range of structural and 
stereochemical variation used in the present work. Gas 
chromatography-mass spectrometry (GC-MS) analysis 
was therefore routinely used for structure determination 
and assignments were confirmed by comparison with 
synthetic lactone standards (for all standards but lactone 
26; full details of the syntheses to be given elsewhere). 
As quantification using GC-MS proved difficult, however, 
once a product structure was identified and the absence 
of stereoisomers confirmed, radiochemical TLC analysis 
was used to determine lactone yields. 
Choice of assay conditions 
In initial assays, the concentration of the natural diketide 
(ZS, 3R)-Z-methyl-3-hydroxy pentanoic acid NAC thioester 
3a was varied, whereas (ZRS)-methylmalonyl-CoA was 
maintained at 600 pM (previously found to be a saturating 
concentration for this substrate [27,28]) and NADPH was 
used at 1 mM (no further increase in production of trike- 
tide lactone was seen using NADPH at higher concentra- 
tions). In order to discriminate between biosynthesis of 
lactones from any propionyl-CoA contaminant in the 
methylmalonyl-CoA [30] and from the diketide substrate, 
radioactivity was added in the form of [14C]-(ZS, 3R)-Z- 
methyl-3-hydroxy pentanoic acid NAC thioester 3b. Use of 
this reagent ensured that any radiolabelled product with 
the same Rras authentic lactone standard was derived from 
diketide only. At the highest level of diketide NAC 
thioester used (6 mM), the yield of triketide lactone under 
these assay conditions was comparable to that seen previ- 
ously using the normal propionyl-Coil substrate to provide 
starter units. In all subsequent experiments, diketide NAC 
substrates were used at a standard concentration of 6 mM. 
In other assays, propionyl-Coil or alternative acyl-CoA 
esters were added at 300 PM, a concentration that, in pre- 
liminary experiments, was found to give the optimum 
yields of triketide lactone from both acetyl-CoA and 
n-butyryl-CoA, under the conditions used (data not shown). 
Results of incorporation experiments 
Structural variation in the chain extension unit: C-2, C-3 
stereochemistry 
The natural diketide intermediate has a (ZS, 3R)-Z- 
methyl-3-hydroxyl configuration, and its incorporation in 
vitro can be detected using GC-MS. In order to discrimi- 
nate between biosynthesis from contaminant propionyl- 
CoA in the methylmalonyl-CoA, and from the diketide 
substrate, specifically deuterated CDs-methylmalonyl- 
CoA was also used. The detection in these experiments of 
triketide lactone molecules containing a single CD, group, 
by GC-MS analysis, confirmed the incorporation of the 
natural diketide analogue (data not shown). Chuck et al. 
[‘24] showed previously that the diastereomeric analogue 5 
failed to incorporate. We have re-evaluated this compound 
as well as the other two stereochemical variants, analogues 
4 and 6. Although identical in functionality to the natural 
substrate, all three failed to incorporate to yield lactones 
17-19, respectively, above GC-MS detection limits. 
Structural variation in the chain extension unit: C-2 alkyl 
substituent 
We looked initially at the feasibility of extending the 
functionality at C-Z from a methyl group to the sterically 
more demanding ethyl group, as well as removing the 
methyl group as had been done previously [24]. Two C-Z 
ethyl diketide analogues were evaluated, one of which, 7, 
has a smaller size starter unit, and the other, 8, has a larger 
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Table 1 
Comparison of triketide lactone yields from CoA thioesters 
(300 pfvl) and their corresponding diketide analogues (6 mM). 
Lactone 
Yield from Yield from 
diketide NAC (nmol) CoA thioester (nmol) 
g” 
2 13* 16 
$H 
17 
23 
24 20 from ll/ 
3.2 from 16 
6.0 
14 
4.7 
*Assuming complete suppression of biosynthesis from contaminant 
propionyl-CoA. 
one. Using GC-MS analysis, we found no evidence for 
incorporation of the acetate-terminal diketide 7. Although 
there was a peak corresponding to incorporation of 8 with 
the correct mass and fragmentation pattern for the 
expected lactone 21, its identity could not be confirmed 
due to lack of the appropriate synthetic standard. As the 
levels of incorporation were small, we did not go on to syn- 
thesise this standard. From this preliminary evidence, it 
Figure 4 
appears that increased bulk at C-Z is only poorly accom- 
modated. This result is in agreement with a recent report 
that replacement of the module 2 acyl transferase (AT) of 
DEBS with the ethylmalonate-specific AT from the nid- 
damycin PKS resulted in only minor amounts of the 
expected ethyl-substituted erythromycin analogue [36]. 
Structural variation in the starter unit 
DEBS I-TE has been shown to accept the unnatural 
starter acids acetyl-CoA, n-butyryl-CoA and iso-butyryl- 
CoA in vitro [32-341. Consequently, diketides including 
these functionalities (9-12) would be expected to incor- 
porate into triketide lactones. The conversion of ana- 
logues 9 and 10 to lactones 22 and 23 has been reported 
previously [24,33,34], and was reproduced under these 
conditions. Likewise, analogues 11 and 12 were shown to 
incorporate into lactones 24 and 2.5, respectively, using 
GC-MS. In addition, as observed previously, the extent 
of conversion, as measured using radiochemical TLC, 
improved with increased chain length of the starter unit 
[24] (Table 1). Although incorporation of the correspond- 
ing starter units has not been reported, we also investi- 
gated the benzoyl diketide 13 and the CD3-labelled 
cyclohexyl diketide 14 under the same conditions. By 
GC-MS analysis and comparison with synthetic standard 
26 (for synthesis, see Figure 4 and the Materials and 
methods section), both the benzoyl diketide 13 and the 
starter unit benzoyl-CoA were shown to incorporate. 
Although a significant peak with the anticipated mass and 
fragmentation pattern of lactone 27 was detected, incor- 
poration of analogue 14 could not be conclusively estab- 
lished without the appropriate synthetic standard 
(cyclohexyl-CoA is not commercially available). 
Synthesis of triketide lactone standard 26. For 
experimental details, see the Materials and 
methods section. Reagents and conditions: 
(i) 1.2 equivalents Bu,BOTf, 1.4 equivalents 
EtsN, CH,CI,, O’C, 20 min; 1 .l equivalents 
benzaldehyde, -78’C, 20 min, then O’C, 2 h; 
(ii) 1 .l equivalents TBDMS triflate, 
1.8 equivalents i-Pr,EtN, CH,CI,, -78’C, 2 h; 
(iii) 1 .l equivalents LiBH,, 1 .l equivalents 
water, Et,O, O”C-+room temperature, then 
room temperature, 1 h; (iv) 1 .l equivalents 
Dess-Martin reagent, CH,CI,, room 
temperature, 40 min; (v) (a) 1.2 equivalents 
Bu,BOTf and 1.3 equivalents Et,N added to 
1 equivalent (4R)-3-propionyl-4-phenylmethyl- 
2-oxazolidinone 29, CH,CI,, -78%, 20 min; 
(b) 1 .l equivalents 28, -78”C, 20 min, then 
O”C, 2 h; (vi) (a) 4.6 equivalents LiOOH, 
THFlwater (3:1), O’C, 20 min; (b) 1 M HCI, 
THF, 4O”C, 4 h. 
1 
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Table 2 
Suppression of lactone biosynthesis from CoA thioesters (300 PM) by diketide NAC thioesters (6 mM). 
Starter unit Diketide 
8H 
(nmol) Yield (nmol) 
2 
Propionyl-CoA 
Propionyl-CoA 
Propionyl-CoA 
n-ButyryCCoA+ 
+ 
+ 
WAC 
4.. 
10 
0 
P 
“#OH 
Free NACSH 1.2 
6.6* 
1.6 
62 
stw+ 
n-Butyryl-CoA + 3a 
*a.. o 
P 
31 5.0 
“‘OH 
l Lactone 2 produced from propionyl-CoA contaminant in the added methylmalonyl-CoA. +Assay(s) conducted with a different batch of proteins, 
hence disparity in yields. 
Comparison of biosynthesis through the loading domain/ 
module 1 and through diketide incorporation at module 2 
The data presented here demonstrate that under the 
chosen conditions in vitro, the same range of starter unit 
structure can be incorporated through either unnatural 
starter acids or their corresponding diketides, even though 
the erythromycin loading domain has been thought to have 
a restricted specificity [32]. As mentioned earlier, however, 
there are many factors that determine the efficiency with 
which substrate analogues can be incorporated in viva. A 
quantitative comparison of efficiency of chain initiation by 
starter CoA-thioesters via the loading domain/KS1 [37] or 
through diketide analogues at module 2 will require, at the 
least, the future development of more sensitive assay 
methods and the elimination of contaminant propionyl- 
CoA to allow initial rates to be measured with acceptable 
accuracy. Meanwhile, it is pertinent to point out that, in 
qualitative terms, to achieve comparable yields of triketide 
lactones from diketide NAC analogues required signifi- 
cantly higher concentrations of theses substrates than of 
the corresponding acyl-CoA thioesters (Table 1). 
Suppression of lactone biosynthesis from acyl CoA thioesters 
by diketide NA C thioesters 
In monitoring triketide lactone synthesis using radiochem- 
ical TLC, it appeared that diketide NAC thioesters sup- 
press chain initiation from CoA-thioesters. To study this 
effect, assays were conducted in the presence of 300 pM 
starter (either propionyl-CoA or n-butyryl-CoA), 6 mM 
diketide NAC (n-butyryl diketide NAC 10 or propionyl 
diketide NAC 3a, respectively), as well as 600 pM methyl- 
malonyl-CoA, 6 pM [14C]-(2RS)-methylmalonyl-CoA and 
1 mM NADPH, and the yields of lactones were compared 
to those from the starter only. An assay was also conducted 
in the presence of propionyl-CoA starter and free NACSH 
(6 mM), because, as shown using GC-MS analysis, 
NACSH is present in the assays with added diketides. 
The data are shown in Table 2. From the results it can be 
concluded that the presence of a diketide NAC substrate 
strongly inhibits biosynthesis from a CoA thioester, even 
when the starter unit is present at saturating concentra- 
tions. The nature of this inhibitory effect is unclear, but if 
it operates in viva it should tend to favour incorporation of 
exogenous diketides into wild-type PKSs. 
Incorporation of p-keto diketides 
The utility of directed biosynthesis would increase if syn- 
thetic diketide analogues could be supplied to the enzyme 
not as B-hydroxy esters but as racemic B-keto esters. To 
assess the viability of this approach, the B-keto analogues 
15 and 16 were incubated with DEBS l-TE and the reac- 
tion mixture was analysed for the presence of lactones 22 
and 24 with the natural stereochemistry, incorporating 
either an acetate or iso-butyrate starter residue, respec- 
tively (although KR2 might have reduced the keto group 
to give the opposite C-Z and C-3 configuration, we had 
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already demonstrated that this stereochemistry is not 
accepted by the PKS). 
Compound 1.5 failed to be processed by DEBS l-TE to 
any significant extent, but GC-MS analysis of methylated 
extracts demonstrated that diketide 16 had been reduced 
stereoselectively and incorporated into lactone 24 (there 
was no evidence for the methyl ester of the triketide cor- 
responding to processing of the unreduced analogue by 
module 2). It appears, therefore, that KRl will reduce a 
diketide keto ester stereospecifically, as has been 
observed previously (I.E. Holzbaur, personal communica- 
tion), and that the resultant P-hydroxy compound is then 
recognised by KS2 for chain extension to the triketide. 
Depending on the substrate tolerance of KRl, feeding of 
racemic fi-keto esters could greatly simplify the synthetic 
work that is required for diketide incorporation studies. 
Significance 
Antibiotic-producing modular polyketide synthases 
(PIG&) are giant multienzymes in which a different set 
of enzyme activities is used to catalyse each successive 
round of chain extension. Previous work has shown that 
analogues of putative enzyme-bound intermediates, par- 
ticularly synthetic diketides as their Nacetylcysteamine 
thioesters, can be incorporated intact in vivo into full- 
length products. We have explored the versatility of this 
strategy through in vitro experiments with a fully puri- 
fied bimodular derivative (DEBS l-TE) of the 6-deoxy- 
erythronolide B synthase. We show here that there is 
considerable scope for variation in the starter unit. 
Increased bulk at the alkyl branch (ethyl for methyl), 
however, is not tolerated to an efficient extent, nor is 
alteration of stereochemistry at C-2 and C-3. The con- 
stituent enzymes of module 2, in this PKS at least, are 
apparently specific enough that the usefulness of diketide 
analogue feeding as a method of generating additional 
diversity in polyketide products will be confined to varia- 
tions in starter unit structure, a type of alteration already 
conveniently achieved by engineering broader specificity 
into the loading module of a PKS. More encouragingly, 
racemic keto analogues of diketides, which are syntheti- 
cally more accessible, are alternatives to hydroxy inter- 
mediates in mutasynthesis. 
Materials and methods 
Materials 
Coenzyme A thioesters were purchased from Sigma, DL-2-[methyl-14C]- 
methylmalonyl-CoA (56.4 mCi/mmol) from DuPont NEN and HPLC 
grade ethyl acetate from Fisher. THF and Et,0 were distilled from lithium 
aluminium hydride, hexane from calcium hydride, and CH,CI, from 
sodium hydride immediately before use. N, N’-dimethylpropyleneurea was 
refluxed over calcium hydride, distilled at reduced pressure, and stored 
over 4 A molecular sieves. N, N-Diisopropylethylamine, N, N-diisopropy 
lamine and triethylamine were refluxed over calcium hydride, distilled, and 
stored over calcium hydride or 4 8, molecular sieves. Flash column chro- 
matography was performed using Merck Kieselgel 60 (40-60 Fm), and 
the indicated solvent systems. All reactions were performed under argon. 
Protein isolation 
Purification of DEBS 1 -TE was performed essentially as described for 
DEBS multienzymes from S. eryfhraea [36], and for over-expressed 
DEBS 3 in Escherichia co/i [391. 
Diketide incorporation assays 
Assays (45 h, 30°C) were conducted in which the concentrations of 
diketide NAC and NADPH were varied relative to a constant level of 
(2RS)-methylmalonyl-CoA (600 FM) as follows: [3a] = 600 PM and 
[NADPH] = 600 PM, 1.2 mM, 3 mM; [3a] = 1.2 mM and [NADPHI = 
1.2mM, 2.4mM, 5.6mM; [3a]=3.0mM and [NADPH]=3.4mM, 
6.4 mM and 14.6 mM; and [3a] = 6.0 mM and [NADPHI = 1 .O mM, 
6.3 mM, 12.4 mM and 27.6 mM. Radioactivity was added in the form of 
[14C]-(2S, 3R)-2-methyl-3-hydroxypentanoic acid NAC 3b (250 yCi/ 
mmol, 2% of total diketide concentration). The assays were carried out 
in 400 mM potassium phosphate buffer (pH 7.5), containing 1 mM 
EDTA and 20% glycerol in a total volume of 500 1.11. Protein concentra- 
tion (250 + 10 pg/ml) was determined by the method of Bradford [401. 
The reaction mixtures were quenched by extraction with two equal 
volumes of HPLC-grade ethyl acetate. The 14C-labeled products were 
separated on TLC plates using diethyl ether as the mobile phase, and 
were counted on a Phosphorimager (Molecular Dynamics) relative to a 
lactone standard of known radioactivity. 
Further incubations (21-45 h, 30%) were carried out in the presence 
of various diketide NAC thioesters (6 mM), (2RS)-methylmalonyl-CoA 
(600 BM), NADPH (1 .O-6.0 mM), and DEBS l-TE. When used, 
radioactivity was added in the form of [“%I-(2f?S)-methylmalonyl-CoA 
(6.0 PM, 54.6 FCilmmol). The assays were carried out in 400 mM 
potassium phosphate buffer (pH 7.5), containing 1 mM EDTA in a final 
volume of 200-500 PI. Protein concentrations (loo-250 f 10 bg/ml) 
were determined by the method of Bradford [40]. The reaction mix- 
tures were in most cases acidified to pH 2-3, quenched by extraction 
with 2-3 equal volumes of HPLC-grade ethyl acetate, and the prod- 
ucts analysed by GC-MS or by radiochemical TLC. Conditions for the 
competition experiments were as above, but a starter-CoA thioester 
was also present at 300 PM and [14C]-methylmalonyl-CoA at 6.0 PM 
(54.6 pCi/mmol). 
Acyl-Coenzyme A thioester assays 
Incubations (23 h, 30°C) were carried out in the presence of various 
starter acyl-CoA thioesters (100, 300 or 600pM), (2RS)-methyl- 
malonyl-CoA (600 PM), [14CI-(2RS)-methylmalonyl-CoA (6.0 ~.LM, 
54.6 yCi/mmol), NADPH (1 .O mM), and DEBS 1 -TE. The assays were 
carried out in 400 mM potassium phosphate buffer (pH 7.5), containing 
1 mM EDTA in a total volume of 200-250 ~1. Protein concentrations 
(loo-250+ 10 pg/ml) were determined by the method of Bradford 
[401. The reaction mixtures were acidified to pH 2-3, quenched by 
extraction with 2 equal volumes of HPLC-grade ethyl acetate, and the 
products analysed by radiochemical TLC. 
Product analysis and characterisation 
GC-MS analysis was carried out with chemical ionisation (methane or 
ammonia as ionisation gas) on a FinniganlMAT GCQ instrument using 
an Anachem SGE BPX5 5% phenyl polysilphenylene-siloxane column 
(inner diameter 0.22 mm, film width 0.25 mm, length 25 m). The fol- 
lowing temperature program was used to analyse the extraction mix- 
tures: 2 min 7O”C, then 20 min, 10 deg/min to 250°C. Melting points 
were determined on a Gallenkamp hot stage melting point apparatus, 
and are uncorrected. Specific optical rotations were recorded on a 
Perkin-Elmer 241 polarimeter (concentration, c, g/l 00 ml solvent). 
Infrared spectra were recorded on a Perkin-Elmer 1600 series FTIR 
spectrometer as solutions between sodium chloride plates. ‘H and 
1% nuclear magnetic resonance spectra were recorded on Bruker 
WM250, AC250, AM400 or AC400 NMR spectrometers. Chemical 
shifts are reported in parts per million relative to tetramethylsilane. 
Mass spectra were recorded on an AEI MS 30 double beam spec- 
trometer (El) or on a Bruker CM547e Fourier Transform Ion Cyclotron 
Resonance (FT-ICR) spectrometer. 
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(4S)-3-Acetyl-4-phenylmethyl-2-oxazolidinone [4 1,421 
n-Butyl lithium (10.7 ml of a 1.8 M solution in hexane, 17.1 mmol, 
1.0 eq) was added dropwise to a stirred solution of (4s)4-phenyl- 
methyl-2-oxazolidinone (3.0 g, 17 mmol, 1 .O eq) in tetrahydrofuran 
(THF) (150 ml) at 0“C. The solution was stirred at O’C for 5 min, 
cooled to -78°C and acetyl chloride (2.2 ml, 2.8 g, 34 mmol, 2.0 eq) 
was added dropwise. The resulting solution was stirred at -78°C for 
1.5 h, allowed to warm to 0°C over 30 min, and then a saturated 
sodium bicarbonate solution (60 ml) was added. The mixture was 
extracted with diethyl ether (3 x 100 ml), the extracts washed with 
brine (50 ml), then dried (Na,SO,) and concentrated in vacua. The 
crude product was purified by flash column chromatography (silica gel, 
20:80 ethyl acetatelhexane) to give 3.4 g (15 mmol, 91%) of (4s)3- 
acetyl-4-phenylmethyl-2-oxazolidinone. [a], = +71.5” (c 1 .l CH,CI,). 
‘H NMR (CDCI, 400MHz) 67.34-7.16 (m, 5H, Ph), 4.65 (m, lH, 
C(4)-H), 4.10 (m, 2H, C(5)-H,), 3.28 (dd, J = 13.4, 3.3 Hz, 1 H, one of 
Ph-CH,), 2.76 (dd, J = 13.4, 9.5 Hz, 1 H, one of Ph-CH,), 2.53 (s, 3H, 
C(2’)-H,). ‘X NMR (CDCI, 100 MHz) 6 170.3, 153.7, 135.3, 129.4, 
129.0, 127.4, 66.1, 55.0, 37.8, 23.8. IR (thin film, cm-‘): 1782, 1697. 
M+ calc’d for C, 2H,3N03: 219.0895; found: 219.0903. 
(4S)-3-[3~-14C]-Propionyl-4-phenylmethyi-2-ox~oiidinone [43] 
Sodium bis(trimethylsilylamide) (1 .O M in THF, 2.5 ml, 2.5 mmol, 
1.1 eq) was cooled to -78’C with stirring and a solution of (4S)-3- 
acetyl-4-phenylmethyl-2-oxazolidinone (0.50 g, 2.3 mmol, 1 .O eq) in 
dry THF (15 ml) and N, K-dimethylpropyleneurea (DMPU) (2.8 ml, 
23 mmol, 10 eq) added dropwise via cannula. The resulting solution 
was stirred at -78°C for 1 h, a solution of [14Cl-methyl iodide (1 mCi) 
and methyl iodide (0.43 ml, 6.8 mmol, 3.0 eq) in dry THF (5 ml) was 
added and then the solution stirred at -78“C overnight. The reaction 
was quenched by the addition of saturated ammonium chloride 
(10 ml) and the volatiles removed in vacua. The slurry was extracted 
with ether (4 x 40 ml), the extracts washed with brine (40 ml), dried 
(Na,SO,) and concentrated in vacua. The crude product was purified 
by flash column chromatography (silica gel, 20% ethyl acetate in 
hexane) to give 0.18 g (0.74 mmol, 32%) of (4S)-3-[3’-14C]-propionyl- 
4-phenylmethyl-2-oxazolidinone. Radiochemical yield 600 uCi, 60%. 
Specific activity 820 uCi/mmol. 
(4s)3-((2’S, 3’R)-3’-Hydroxy-2’-[14CI-methylpentanoyl-4- 
phenylmethyl-2-oxazolidinone [4 I] 
Di-n-butylboron triflate (0.20 ml, 0.80 mmol, 1 .l eq) and N, N-diiso- 
propylethylamine (0.15 ml, 0.88 mmol, 1.2 eq) were added dropwise to 
a stirred solution of (4S)-3-[3’-14Cl-propionyl-4-phenylmethyl-2-oxazo- 
lidinone (0.17 g, 0.73 mmol, 1 .O eq) in dry dichloromethane (5 ml) at 
O’C. The resulting solution was stirred at -78°C for 30 min. Propi- 
onaldehyde (2.0 M in dichloromethane (CH,CI,), 0.44 ml, 0.88 mmol, 
1.2 eq) was added dropwise and then the solution stirred at -78“C for 
30 min and at O’C for 2 h. The reaction was quenched by the addition 
of pH 7 phosphate buffer (2 ml) and methanol (6 ml). A 2:l mixture of 
methanol/hydrogen peroxide (27 wt% in H,O) (6 ml) was added drop- 
wise at O’C and the resulting solution stirred at 0°C for 1 h. The 
volatiles were removed in vacua and the slurry extracted with ether 
(4 x 30 ml). The extracts were washed with 5% sodium hydrogen car- 
bonate (20 ml) and brine (20 ml), dried (Na,SO,) and concentrated in 
vacua. The crude product was purified by flash column chromatogra- 
phy (silica gel, 5% ethyl acetate in hexane) to afford 0.14 g (0.48 mmol, 
65%) of (4s)3-((2’S, 3’R)-3’-hydroxy-2’-[14Cl-methylpentanoyl-4- 
phenylmethyl-2-oxazolidinone. Specific activity 810 uCi/mmol. 
(2S, 3R)-3-Hydroxy-2-[14C]-methylpentanoic acid [441 
(4S)-3-((2’S, 3’R)-3’-Hydroxy-2’-[i4C]-methylpentanoyl-4-phenylmethyl- 
P-oxazolidinone (0.14 g, 0.47 mmol, 1.0 eq) was dissolved in 3:l 
THF/water (30 ml) at O°C. Hydrogen peroxide (27 wt% in H,O, 
0.72 ml, 5.7 mmol, 12 eq) was added dropwise followed by lithium 
hydroxide (0.060 g, 1.4 mmol, 3.0 eq). The resulting solution was 
stirred at room temperature for 75 min before cooling to 0“C and 
quenching with sodium sulphite (1.5 M, 3.2 ml, 4.7 mmol, 10 eq). The 
volatiles were removed in vacua and the remaining aqueous solution 
extracted with dichloromethane (4 x 20 ml). The aqueous layer was 
cooled to 0°C and acidified to pH 1 with 3 M hydrochloric acid. This 
layer was then extracted with saturated sodium chloride, extracted with 
ethyl acetate (4 x 20 ml), dried (Na,SO,) and concentrated in vacua to 
give 0.063 g (0.47 mmol, 100%) of (2S, 3fl-3-hydroxy-2-[14Cl- 
methylpentanoic acid. Specific activity 800 @/mmol. 
P’-(Acetylamino)ethyl (2S, 3R)-3-hydroxy-2-[74Cl-methyl- 
pentanethioate 3b [45,46] 
(2S, 3/?)-3-Hydroxy-2-[14Cl-methylpentanoic acid (0.063 g, 0.47 mmol, 
1.0 eq) was dissolved in dry dichloromethane (2.0 ml) at O’C and 
4-dimethylaminopyridine (12.0 mg, 0.095 mmol, 0.20 eq) added. 
N-acetylcysteamine (1 .O M in CH,CI,, 0.71 ml, 0.71 mmol, 1.5 eq) 
and 1, 3-dicyclohexylcarbodiimide (DCC) (1 .O M in CH,CI,, 0.52 ml, 
0.52 mmol, 1.1 eq) were added dropwise and the resulting solution 
stirred at O’C for 10 min and then at room temperature overnight. The 
precipitate was removed by filtration through Celite and the filtrate 
concentrated in vacua. The crude product was purified by flash 
column chromatography (silica gel with 1 cm plug of CuSO,-impreg- 
nated silica, 5% methanol in ethyl acetate) to give 0.082 g 
(0.35 mmol, 74%) of 2’-(acetylamino)ethyl (2S,3R)-3-hydroxy-2-[14Cl- 
methylpentanethioate 3b. Specific activity 780 uCi/mmol. 
(4S)-3-Acetyl-4-isopropyl-2-oxazolidinone [4 1,421 
n-Duty1 lithium (18.5 ml of a 1.6 M solution in hexane, 29.6 mmol, 
1 .l eq) was added dropwise to a stirred solution of (4s)4-isopropyl- 
2-oxazolidinone (3.56 g, 27.6 mmol, 1 .O eq) in tetrahydrofuran (THF) 
(80 ml) at O‘C. The solution was stirred at 0°C for 20 min, cooled to 
-78“C, and acetyl chloride (2.2 ml, 2.4 g, 31 mmol, 1.0 eq) was 
added dropwise. The reaction was allowed to warm to 0°C over 1 h 
and a saturated sodium bicarbonate solution (50 ml) was added. The 
mixture was extracted with diethyl ether (3 x 50 ml), and then the 
extracts combined, dried (MgSO,) and concentrated in vacua. The 
crude product was purified by flash column chromatography (silica 
gel, 30:70 ethyl acetate/hexane) to give 4.29 g (26.9 mmol, 91%) of 
(4S)-3-acetyl-4-isopropyl-2-oxazolidinone. [cd0=+105” (c 1.4 
CH,CI,). ‘H NMR (CDCI, 400 MHz) 64.34 (ddd, 1 H, J =8.2, 3.3, 
3.3 Hz, C(4)-H), 4.19 (dd, J = 9.1, 8.2 Hz, 1 H, one of C(5)-H,), 4.13 
(dd, lH, J =9.1, 3.3 Hz, one of C(5)-Ha), 2.43 (s, 3H, C(2’)-H,), 
2.33-2.25 (m, 1 H, C(6)-H), 0.83 (d, J = 7.1 Hz, 3H, one of C(G)-CH,), 
0.78 (d, J= 7.0 Hz, 3H, one of C(G)-CH,). 13C NMR (CDCI, 
1OOMHz) 6170.0, 154.1, 63.0, 58.1, 28.3, 23.5, 17.7, 14.4. IR (thin 
film, cm-r): 1782, 1704. M+ calc’d for C,H,,NO,: 171.0895; found: 
171.0890. 
(4S)-4-lsopropy1-3-(~3~-2H,l-propionyl)?-oxazolidinone 1431 
A -78’C solution of (4S)-3-acetyl-4-isopropyl-2-oxazolidinone (1.31 g, 
7.66 mmol, 1 .O eq) and DMPU (9.2 ml, 9.8 g, 77 mmol, 10 eq) in THF 
(15 ml) was added dropwise via cannula to a stirred solution of 
sodium hexamethyldisilylamide (8.5 ml of a 1 M solution in THF, 
8.5 mmol, 1 .l eq) at -78°C. The mixture was stirred for 1 h, and then 
a -50°C solution of [*H,l-methyl iodide (2.2 ml, 5.0 g, 34 mmol, 
4.5 eq) in dry THF (3 ml) was added via cannula. The reaction was 
allowed to warm to room temperature over 16 h and then quenched 
by the addition of saturated ammonium chloride (30 ml). The resulting 
mixture was extracted with ether (3 x 50 ml) and then the combined 
extracts dried (Na,SO,) and evaporated in vacua. The crude product 
was purified by flash chromatography (silica gel, 30:70 ethyl 
acetate/hexane) to give 1 .Ol g (5.36 mmol, 70%) of (4s)4-isopropyl- 
3-([3’-2Hs]-propionyl)2-oxszolidinone. [a], = +91.8’ (c 1.2 CH,CI,). 
‘H NMR (CDCI, 250 MHz) 6 4.39 (ddd, 1 H, J = 9.0, 3.1, 3.1 Hz, 
C(4)-H), 4.22 (dd, J =9.0, 9.0 Hz, lH, one of C(5)-Ha), 4.18 (dd, lH, 
J=9.0, 3.3 Hz, one of C(5)-H,), 2.92 (d, J= 17.7 Hz, lH, one of 
C(2)-H,), 2.84 (d, J = 17.7 Hz, lH, one of G(2’)-Ha), 2.34 (dqq, 
J = 7.0, 7.0, 3.1 Hz, 1 H, C(6)-H), 0.88 (d, J = 7.0 Hz, 3H, one of C(6)- 
CH,), 0.84 (d, J = 7.0 Hz, 3H, one of C(6)-CH,). 13C NMR (CDCI, 
1OOMHz) 6174.0, 154.1, 63.2, 58.3, 28.8, 28.3, 17.9, 14.5, 8.4 
(septet, J,-o 19.4 Hz, CD,). IR (thin film, cm-l): 1781, 1702. M+ 
calc’d for C,H,,D,NO,: 188.1240; found: 188.1245. 
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(4S)-3-((2’R,3’S)-~2”-2H,]-3~-Cyclohexyl-3’-hydroxyl?~-methyl- 
propionyl)-4-isopropyl-2-oxazoiidinone I4 11 
N, N-Diisopropylethylamine (0.40 ml, 0.30 g, 2.3 mmol, 1 .l eq) and di-n- 
butyl boron triflate (0.60 ml, 0.66 g, 2.4 mmol, 1.2 eq) were added 
sequentially to a stirred solution of (4S)-4-isopropyl-3-([3’-2Hs)-propi- 
onyl)-2-oxazolidinone (0.36 g, 2.0 mmol, 1 .O eq) in dry dichloromethane 
(4 ml) at 0°C. The resulting solution was stirred at O’C for 45 min and 
then cooled to -78°C. Cyclohexanecarboxaldehyde (0.30 ml, 0.28 g, 
2.4 mmol, 1.2 eq) was added dropwise and the solution stirred at 
-78°C for 30 min, warmed to O’C and stirred for a further 2 h. The reac- 
tion was quenched by the addition of pH 7 phosphate buffer (3 ml), the 
organic layer separated and the aqueous layer extracted with ether 
(3 x 10 ml). All organic extracts were combined, the solvent removed in 
vacua, and the crude product was redissolved in a 1 :l mixture of pH 7 
phosphate buffer/methanol (6 ml). This solution was cooled to O’C, 
hydrogen peroxide (0.83 ml of a 30% solution in water, 7.3 mmol, 
3.6 eq) added carefully and the resulting mixture stirred at 0% for 1 h. 
Methanol was removed in vacua and the aqueous layer extracted with 
dichloromethane (3 x 25 ml). The extracts were combined, dried 
(Na,SO,) and the solvent removed in vacua. The crude product was 
purified by flash column chromatography (silica gel, 25:75-35:65 ethyl 
acetatelhexane) to give 0.50 g (1.7 mmol, 83%) of (4S)-3-((2’S, 3’R)- 
[2”-*H,]-3’-cyclohexyl-3’-hydroxyl-2’-methylpropionyl)-4-isopropyl-2-oxa- 
zolidinone. m.p. 82-84X [clI,=+68.8’ (c 1.05 CHCI,). ‘H NMR 
(CDCI, 400 MHz) 6 4.45 (ddd, 1 H, J = 9.0, 3.1, 3.0 Hz, C(4)-H), 4.28 
(dd, J = 9.0, 9.0 Hz, 1 H, one of C(5)-H,), 4.21 (dd, 1 H, J = 9.0, 3.1 Hz, 
one of C(5)-H,), 3.93 (d, J = 2.3 Hz, 1 H, C(2’)-H), 3.57 (ddd, J =8.7, 
2.9, 2.3 Hz, lH, C(3’)-H), 3.00 (d, J =2.9 Hz, lH, OH), 2.38-2.30 (m, 
1 H, C(6)-H), 2.1 l-2.08 (m, lH), 1.75-1.71 (m, 2H), 1.66-1.62 (m, 
2H), 1.41-l .35 (m, 1 H, C(4’)-H), 1.25-l .09 (m, 3H), 1 .OO-0.95 (m, 
2H), 0.91 (d, J = 7.0 Hz, 3H, one of C(6)-CH,), 0.87 (d, J = 6.8 Hz, 3H, 
one of C(G)-CH,). 13C NMR (CDCI, 100 MHz) 6 178.2, 153.4, 75.1, 
63.3, 58.2, 40.0, 38.9, 29.6, 28.8, 28.3, 26.3, 26.0, 25.9, 17.9, 14.7, 
9.5 (septet, Jc-o 19.4 Hz, CD,). IR (thin film, cm-‘): 3600-3450, 1779, 
1682. M+ calc’d for C,sH,,D,NO,: 301.2206; found: 301.2214. 
(2S, 3R)-[2’-2H~-3-Cyclohexyl-3-hydroxy-2-methylpropionic 
acid [44] 
Hydrogen peroxide (2.6 ml of a 30% solution, 23 mmol, 14 eq) and 
lithium hydroxide (0.21 g, 5.1 mmol, 3.0 eq) were added to a stirred 
solution of (4s)3-((2’S, 3’R)-[2”-*H,]-3’-cyclohexyl-3’-hydroxyl-2’- 
methylpropionyl)-4-isopropyl-2-oxazolidinone (0.50 g, 1.7 mmol, 1 .O eq) 
in a 3:l mixture of THF/water (32 ml) at 0°C. The reaction mixture was 
stirred at room temperature for 1 h, cooled to 0% and quenched with 
sodium sulphite solution (5.2 ml of a 1.5 M solution in water, 7.8 mmol, 
4.6 eq). The THF was removed in vacua and the aqueous solution 
extracted with dichloromethane (3 x 15 ml). The aqueous layer was 
acidified to pH 1 by addition of 3 M hydrochloric acid, and then re- 
extracted with ethyl acetate (3 x 15 ml). The organic extracts were com- 
bined, dried (Na,SO,) and the solvent removed in vacua to give 0.30 g 
(1.6 mmol, 95%) of (2S, 3R)-[2’-2Hsl-3-cyclohexyl-3-hydroxy-2~methyl- 
propionic acid. [o]o= +1.3” (c 1.2 CH,CI,). ‘H NMR (CDCI, 400 MHz) 
6 7.67 (brs, lH, OH), 3.71 (dd, J=8.4, 3.1 Hz, lH, C(3)-H), 2.69 (d, 
J =3.1 Hz, lH, C(2)-H), 2.08-2.04 (m, lH), 1.76-1.64 (m, 3H), 
1.56-1.51 (m, lH), 1.41-1.37 (lH, m, C(4)-H), 1.26-1.10 (m, 3H), 
1.02-0.93 (m, 2H). 13C NMR (CDCI, 1OOMHz) 181.4, 75.9, 41.0, 
39.9, 29.1, 28.9, 26.2, 25.9, 25.9. IR (thin film, cm-l): 3500-3250, 
1716. M+ calc’d for C,,H,,D,O,: 190.1552; found: 190.1526. 
S((2S, 3R)-[2’-2H,]-3-Cyclohexyl-3-hydroxy-2-methyl- 
propionyl)2-acetamidoethanethiol 14 [45,46] 
A few crystals of 4-dimethylaminopyridine were added to a stirred solu- 
tion of (2S, 3R)-[2’-2H3]-3-cyclohexyl-3-hydroxy-2-methylpropionic acid 
(0.30 g, 1.6 mmol, 1 .O eq) in dry dichloromethane at 0°C. To this mixture 
was added N-acetylcysteamine (2.4 ml of a 1 M solution in dichloro- 
methane, 2.4mmol, 1.5eq) and DCC (2.4 ml of a 1 M solution in 
dichloromethane, 2.4 mmol, 1.5 eq). The reaction was stirred at “C for 
10 min and then at room temperature for 20 h. The mixture was then fil- 
tered through Celite, washed with ethyl acetate and concentrated in 
vacua. The crude product was purified by flash column chromatography 
(silica gel, ethyl acetate) to give 0.32 g (1 .l mmol, 67%) of S((2S, 3R)- 
[2’-*H3]-3-cyclohexyl-3-hydroxy-2-methylpropionyl)-2-acetamidoethane- 
thiol 14. [a], = +23.5’ (c 1.2 CH,CI,). ‘H NMR (CDCI, 400 MHz) 
66.48 (brs, lH, NH), 3.58 (dd, J=7.8, 3.6 Hz, lH, C(3)-H), 
3.37-3.35 (m, 2H, CH,N), 2.94-2.92 (m, 2H, CH,S), 2.77 (d, 
J=3.6 Hz, lH, C(2)-H), 2.57 (brd, J=6.6 Hz, OH), 1.88 (s, 3H, 
CH,CO), 1.72-1.56 (m, 3H), 1.49-1.46 (m, 2H), 1.30-1.22 (m, lH), 
1.20-1.03 (m, 3H), 0.99-0.89 (m, 2H). 13C NMR (CDCI, 100 MHz) 
204.0, 170.6, 76.1, 50.1, 40.3, 39.1, 29.1, 28.8, 28.3, 26.1, 25.9, 
25.7, 22.9. IR (thin film, cm-t): 3302, 1659. M+ calc’d for 
C,,H,,D,NO,S: 291 .1822; found: 291 .1804. 
(4S)-3-[(2’R)-2’-Methyl-3’-oxobutanoyll-4-phenyImethyl-2- 
oxazolidinone 1471 
n-Butyl lithium (1.6 ml of a 1.6 M solution in hexane, 2.5 mmol, 1.2 eq) 
was added to a solution of N, N-diisopropylamine (0.35 ml, 2.5 mmol, 
1 .l eq) in THF at -78%. After stirring for 20 min, a solution of (4s)3- 
propionyl-4-phenylmethyl-2-oxazolidinone (0.50 mg, 2.2 mmol, 1 eq) in 
THF (5 ml) was added. The resulting mixture was stirred at -78’C for 
2 h. A 2.5 M solution of magnesium bromide etherate in ether (1 .O ml, 
2.5 mmol, 1.1 eq) was added, and the resulting suspension was 
allowed to warm towards 0% for 2 min and then rapidly cooled to 
-78%. A solution of acetyl chloride (0.19 ml, 2.7 mmol, 1.2 eq) in THF 
(3 ml) was added, and the solution left to stir at -78°C for 30 min 
before quenching with saturated aqueous ammonium chloride (10 ml). 
The solution was warmed to room temperature, the volatile solvents 
removed in vacua, and the resulting aqueous slurry was extracted with 
ether. The organic extracts were washed with saturated aqueous 
sodium bicarbonate and brine, dried (MgSO,) and concentrated under 
reduced pressure. The crude product was purified by flash column 
chromatography (silica gel, 30% ethyl acetate in light petroleum), to 
yield 0.28 g (1 .O mmol, 48%) of (4S)-3-[(2’R)-2’-methyl-3’-oxobu- 
tanoyll-4-phenylmethyl-2-oxazolidinone. m.p. 91-93°C. [al, = -38.1’ 
(c 1.22 CHCI,). IH NMR (CDCI, 400 MHz) 6 7.35-7.24 (m, 5H, Ph- 
H), 4.66 (m, 1 H, C(4)-H), 4.53 (q, J = 7.3 Hz, 1 H, C(2)-H), 4.17 (m, 
2H, C(5)-H,), 3.43 (dd, J = 13.6, 3.3 Hz, 1 H, one of C(4)-CH,), 2.76 
(dd, 1 H, J = 13.6, 10.0 Hz, one of C(4)-CH,), 2.33 (s, 3H, C(4’)-H,), 
1.44 (d, J = 7.3 Hz, 3H, C(P’)-CH,). 13C NMR (CDCI, 100 MHz) 
6 205.2, 169.8, 153.8, 135.4, 129.5, 129.0, 127.3, 66.4, 55.4, 53.0, 
37.5, 28.4, 12.4. IR (thin film, cm-‘): 1776, 1718. M+ calc’d for 
C,,H, ,NO,: 275.1158; found: 275.1 151. 
P’-(Acetylamino)ethyl2-methyl-3-oxobutanoylthioate 15 1481 
Lithium bis(trimethylsilylamide) (1.25 ml of a 1 M solution in THF, 
1.25 mmol, 2 eq) was added to a solution of N-acetylcysteamine 
(0.19 g, 1.6 mmol, 2.5 eq) in THF (40 ml) at -78%. The resulting solu- 
tion was stirred for 15 min at -78’C and then a solution of (4s)3- 
[(2’R)-2’-methyl-3’-oxobutanoyl]-4-phenylmethyl-2-oxazolidinone (0.17 g, 
0.64 mmol, 1 eq) in THF (20 ml) was added. The resulting solution was 
stirred for 15 min at -78°C and at 0°C for 45 min before quenching with 
saturated aqueous ammonium chloride (20 ml). The volatile solvents 
were removed and the aqueous slurry was extracted with ether. The 
organic extracts were washed with brine, dried (MgSO,) and concen- 
trated in vacua. The crude mixture was purified by column chromatogra- 
phy (2 cm copper sulphate-impregnated silica gel, 25:75-35:65 ethyl 
acetatelhexane), to yield 0.074 g (0.35 mmol, 55%) of 2’-(acety 
lamino)ethyl 2-methyl-3-oxobutanoylthioate 15. ‘H NMR (CDCI, 
250 MHz) 6 6.16 (br s, 1 H, NH), 3.71 (q, J = 7.1 Hz, 1 H, C(2)-H), 3.36 
(m, 2H, CH,N), 3.03 (m, 2H, CH,S), 2.19 (s, 3H, NCOCH,), 1.92 (s, 
3H, C(4)-H,), 1.33 (d, J = 7.1 Hz, 3H, C(2)-H,). 13C NMR (CDCI, 63 
MHz) 202.7, 196.9, 170.5, 61.9, 39.2, 28.9, 28.5, 23.1, 13.5. IR (thin 
film, cm-l): 3294, 3077, 1724, 1666. [M+Hl+ calc’d for C,H,,NO,S: 
218.0851; found: 218.0852. 
(4S)-3-[(2’R)-2~4’-Dimethyl-3’-oxopentanoyll-4-phenylmethyl- 
P-oxazolidinone [4 71 
n-Butyl lithium (1.6 ml of a 1.6 M solution in hexane, 2.5 mmol, 1.2 eq) 
was added to a solution of N, N-diisopropylamine (0.35 ml, 2.5 mmol, 
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1 .l eq) in THF at -78°C. After stirring for 20 min, a solution of (4s)3- 
propionyl-4-phenylmethyl-2-oxazoiidinone (0.50 g, 2.2 mmol, 1 eq) in. 
THF (5 ml) was added. The resulting mixture was stirred at -78°C for 
2 ha A 2.5 M solution of magnesium bromide etherate in ether (1 .O ml, 
2.5 mmol, 1.1 eq) was added, and the resulting suspension was 
allowed to warm towards 0°C for 2 min and then rapidly cooled to 
-78’C. A solution of iso-butytyl chloride (0.28 ml, 2.7 mmol, 1.2 eq) in 
THF (3 ml) was added, and the solution left to stir at -78’C for 30 min 
before quenching with saturated aqueous ammonium chloride (10 ml). 
The solution was warmed to room temperature, the volatile solvents 
removed in vacua, and the resulting aqueous slurry was extracted with 
ether. The organic extracts were washed with saturated aqueous 
sodium bicarbonate and brine, dried (MgSO,) and concentrated under 
reduced pressure. The crude product was purified by column chro- 
matography (silica gel, 204/o ethyl acetate in light petroleum) to yield 
0.37 g (1.2 mmol, 57%) of (4S)-3-[(2’R)-2’, 4’-dimethyl-3’-oxopen- 
tanoyfl-4-phenylmethyl-2-oxazolidinone. m.p. 88-90°C. [a], = -23.5 
(c 1.02 CHCI,). ‘H NMR (CDCI, 250 MHz) 6 7.35-7.23 (m, 5H, Ph- 
H), 4.79 (q, J = 7.0 Hz, 1 H, C(2’)-H), 4.65 (m, 1 H, C(4)-H), 4.16 (m, 
2H, C(5)-H,), 3.47 (dd, J= 13.5, 3.3 Hz, lH, one of C(4)-CH,), 2.86 
(m, 1 H, C(4’)-H), 2.75 (dd, J = 13.5, 10.2 Hz, 1 H, one of C(4)-CH,), 
1.43 (d, J= 7.3 Hz, 3H, C(P’)-CH,), 1.22 (d, J =6.9 Hz, 3H, one of 
C(4’)-CH,), 1.15 (d, J = 6.8 Hz, 3H, one of C(4’)CHs). ‘sC NMR 
(CDCI, 63MHz) 6211.6, 170.5, 153.5, 135.5, 129.4, 128.9, 127.2, 
66.3, 55.4, 51.2, 39.1, 37.5, 18.8, 18.8, 12.7. IR (thin film, cm-l): 
1770, 1714. M+ calc’d for C,,H,,NO,: 303.1471; found: 303.1471. 
P’-(Acetylamino)ethyl2,4-dimethyl-3-oxopentanoylthioate 
16 [48] 
Lithium bis(trimethylsilylamide) (1.3 ml of a 1 M solution in THF, 1.3 mmol, 
2 eq) was added to a solution of N-acetylcysteamine (0.20 g, 1.7 mmol, 
2.6 eq) in THF (50 ml) at -78’C. The resulting solution was stirred for 
15 min at -78°C and then a solution of (4s)3-[(2’R)-2’, 4’-dimethyKt’- 
oxopentanoyll-4-phenylmethyl-2-oxazolidinone (0.20 g, 0.64 mmol, 1 eq) 
in THF (20 ml) was added. The resulting solution was stirred for 15 min 
at -78°C and at O’C for 45 min before quenching with saturated 
aqueous ammonium chloride (20 ml). The volatile solvents were removed 
and the aqueous slurry was extracted with ether. The organic extracts 
were washed with brine, dried (Mg.50,) and concentrated in vacua. The 
crude mixture was purified by column chromatography (2 cm copper sul- 
phate-impregnated silica gel, ethyl acetate) to yield 0.1 1 g (0.46 mmol, 
71%) of 2’-(acetylamino)ethyI 2, 4-dimethyl-3-oxopentanoylthioate 16. 
‘H NMR (CDCI, 250 MHz) 6 6.21 (br s, 1 H, NH), 3.93 (q, J = 7.0 Hz, 
lH, C(2)-H), 3.34 (m, 2H, CH,N), 3.01 (m, 2H, CH,S), 2.78 (sep, 
J = 7.0 Hz, 1 H, C(4)-H), 1.92 (s, 3H, NCOCH,), 1.32 (d, J = 7.0 Hz, 3H, 
C(S)-CH,), 1.06 (d, J= 7.0 Hz, 6H, 2 x C(4)CHs). 13C NMR (CDCI, 
63MHz) 208.8, 196.6, 170.5, 59.1, 40.4, 39.2, 28.7, 23.0, 18.5, 18.1, 
13.9. IR (thin film, cm-l): 3292, 3078, 1715, 1650, 1556. M+ calc’d for 
C,,H,,NO,S: 245.1086; found: 245.1086. 
(4S)-3$(2’S, 3’S)-3~-Hydroxy-P~-methyl9’-phenylpropanoyi~- 
4phenylmethyl2-oxazolidinone [411 
Di-n-butylboron triflate (6.5 ml, 25 mmol, 1.2 es) and triethylamine 
(4.0 ml, 30 mmol, 1.4 eq) were added dropwise to a stirred solution of 
(4S)-3-propionyl-4-phenylmethyl-2-oxazolidinone (5.0 g, 21 mmol, 1 .O eq) 
in dry dichloromethane (50 ml) at 0“C. The resulting solution was stirred 
at -78°C for 20 min. Freshly distilled benzaldehyde (2.4 ml, 24 mmol, 
1 .l eq) was added dropwise, then the solution stirred at -78°C for 
20 min and at O’C for 2 h. The reaction was quenched by the addition of 
pH 7 phosphate buffer (24 ml) and methanol (71 ml). A 2:l mixture of 
methanol/hydrogen peroxide (27 wt% in H,O) (71 ml) was added drop 
wise at 0°C and the resulting solution stirred at 0°C for 1 h. The volatiles 
were removed in vacua and the slurry extracted with ether (3 x 50 ml). 
The extracts were washed with 5% sodium sulphite solution (30 ml), 
and then extracted with diethyl ether (50 ml). The combined extracts 
were dried (MgSO,) and concentrated in Iracuo. The crude product 
was purified by flash column chromatography (silica gel, 20% ethyl 
acetate in light petroleum) to afford 5.4 g (16 mmol, 76%) of (4s)3- 
[(2’S, 3’S)-3’-hydroxy-2’-methyI-3’-phenylpropanoyl]-4-phenylmethyl-2- 
oxazolidinone. [o]e = +44’ (c 1.50 CHCI,). l H NMR (CDCI, 400 MHz) 
6 7.41-7.17 (m, 1 OH, 2 x Ph-H), 5.09 (m, 1 H, C(3’)-H), 4.60 (m, 1 H, 
C(4)-H), 4.10 (m, 3H, C(5)-H, and C(2)-H), 3.24 (dd, J = 13.4, 3.3 Hz, 
1 H, one of C(4)-CH,), 3.09 (d, J = 2.7 Hz, 1 H, OH), 2.76 (dd, J = 13.4, 
9.5 Hz, 1 H, one of C(4)-CH,), 1.22 (d, J = 6.9 Hz, 3H, C(2’)CHs). 
13C NMR (CDCI, 100 MHz) 6 176.8, 152.9, 141.3, 135.0, 129.4, 
129.0, 128.3, 127.6, 127.4, 126.1, 73.8, 66.2, 55.2, 44.6, 37.8, 11.0. 
IR (thin film, cm-l): 1769, 1694. [M+Na+]+ calc’d for C,,H2,N0,Na: 
362.1363; found: 362.1358. 
(4S)-3-1(2’S, 3’S)-3’-[(tert-ButyldimethyIsilyl)oxy]-2’-methyl-3~- 
phenylpropanoyll-4-phenylmethyl-2-oxazolidinone 1491 
N, N-Diisopropylethylamine (2.1 ml, 12 mmol, 1.8 eq) and tert-butyl- 
dimethylsilyl triflate (1.5 ml, 6.9 mmol, 1 .l eq) were added to a solution 
of (4S)-3-[(2’S, 3’S)-3’-hydroxy-2’-methyl-3’-phenylpropanoyl]-4-phenyl- 
methyl-2-oxazolidinone (2.2 g, 6.5 mmol, 1 eq) in dry dichloromethane 
(100 ml) at -78’C. The solution was stirred for 2 h at -78’C, and then 
the volatiles removed in vacua. The crude product was purified by flash 
column chromatography (30% ethyl acetate in light petroleum) to yield 
2.2 g (4.8 mmol, 74O/o) of (45)3-[(2’S, 3’S)-3’-[fert-butyldimethyl- 
silyl)oxy]-2’-methyl-3’-phenylpropanoyl]-4-phenylmethyl-2-oxazolidinone. 
[& = +59’ (c 1.86 CHCI,). ‘H NMR (CDCI, 250 MHz) 6 7.43-7.16 
(m, lOH, 2x Ph-H), 4.84 (d, J 7.0 Hz, lH, C(3’)-H), 4.26 (m, lH, C(4)- 
H), 4.16 (qn, J=7.0 Hz, lH, C(2’)-H), 3.98 (dd, J=8.9, 1.9 Hz, lH, 
one of C(5)-Hz), 3.68 (t, J = 8.2 Hz, 1 H, one of C(5)-Hz), 3.20 (dd, 
J = 13.3, 3.2 Hz, 1 H, one of C(4)-CH,), 2.69 (dd, J = 13.3,9.7 Hz, 1 H, 
one of C(4)-CH,), 1.30 (d, J = 6.7 Hz, 3H, C(2’)-CH,), 0.88 (s, 9H, t- 
Bu-H), 0.015 (s, 3H, one of SkCH,), -0.23 (s, 3H, one of Si-CH,). 
13C NMR (CDCI, 63 MHz) 6 174.6, 142.9, 135.4, 129.4, 128.9, 
127.9, 127.4, 127.3, 126.7, 76.6, 65.9, 55.7, 46.7, 37.7, 25.7, 18.1, 
12.9, -4.7, -5.3. IR (thin film, cm-l): 1783, 1698. [M+H+]+ calc’d for 
C,,H,,NO,Si: 454.2408; found: 454.2399. 
(2S, 3S)-3[(tert-butyldimethylsilyl)oxyl-2-methyl5- 
phenylpropanol [SOI 
Water (0.10 ml, 5.6 mmol, 1.1 eq) and lithium borohydride (2.9 ml of 
a 2 M solution in hexane, 5.8 mmol, 1 .l eq) were added to a solution 
of (4s)3-[(2’S, 3’S)-3’-[tert-butyldimethylsilyl)oxy]-2’-methyl-3’-phenyl- 
propanoyll-4-phenylmethyl-2-oxazolidinone (2.3 g, 5.1 mmol, 1 .O eq) in 
diethyl ether at O’C. The solution was warmed to room temperature and 
stirred for 1 h. The reaction was then quenched with 1 M sodium hydrox- 
ide (100 ml), stirred for 10 min and then extracted with diethyl ether 
(3 x 100 ml). The extracts were washed with brine (100 ml), dried 
(MgSO,) and concentrated in vacua. The crude product was purified by 
flash column chromatography (silica gel, 10% ethyl acetate in light petro- 
leum) to yield 0.72 g (2.6 mmol, 51%) of (2S, 3S)-3[(terkbutyldimethylsi- 
lyl)oxy]-2-methyl-5-phenylpentanoyl. [cx]o = -57’ (c 2.93 CHCI,). ‘H 
NMR (CDCI, 250 MHz) 6 7.40-7.12 (m, 5H, Ph-H), 4.84 (d, J =4.3 Hz, 
lH, OH), 3.57 (m, lH, one of C(l)-Hz), 3.42 (m, lH, one of C(l)-Hz), 
2.57 (s, lH, OH), 2.04 (m, lH, C(2)-H), 0.89 (s, 9H, f-Bu-H), 0.74 (d, 
J = 7.0 Hz, 3H, C(P)-CH,), 0.040 (s, 3H, one of SkCHs), -0.19 (s, 3H, 
one of Si-CH,). l3C NMR (CDCI, 63 MHz) 6 142.4, 127.8, 127.1, 
126.8, 65.5, 43.0, 25.8, 18.2, 11.9, -4.65, -5.29. IR (thin film, cm-l): 
3387. [M+H+]+ calc’d for C,,H,,O,Si: 281 .1931; found: 281 .1932. 
(2S, 3S)-3-[(tert-ButyldimethyIsilyl)oxyl-2-methyld- 
phenylpropanal15 l-531 
(2S, 3R)-3[(tert-butyldimethylsilyl)oxy]-2-methyl-5-phenylpentanoyl (0.60 g, 
2.1 mmol, 1 .O eq) in dichloromethane (50 ml) was added to a suspension 
of Dess-Martin reagent (1 .O g, 2.4 mmol, 1.1 eq). The reaction was 
stirred for 40min at room temperature, and then 1 M sodium 
hydroxide/ether 5:12 (170 ml) added. The aqueous layer was extracted 
with diethyl ether (100 ml), and then the organic extracts dried (MgSO,) 
and the solvent removed in vacua. The crude product was purified by 
flash column chromatography to yield 0.48g (1.7 mmol, 71%) of (2S, 
3S)-3-[(tert-butyldimethylsilyl)o~]-2-methyl-5-phenylpropanal. [o$ = -32“ 
(c 1.31 CHCI,). ‘H NMR (CDCI, 250 MHz) 6 9.77 (d, J = 1.3 Hz, 1 H, 
C(l)-H), 7.37-7.20 (m, 5H, Ph-H), 5.15 (d, J = 4.3 Hz, C(4)-H), 2.59 (m, 
1 H, C(2)-H), 1.04 (d, J = 7.0 Hz, 3H, C(2)-CH,), 0.89 (s, 9H, t-Bu-H), 
0.035 (s, 3H, one of Si-CH,), -0.17 (s, 3H, one of Si-CH,). 13C NMR 
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(CDCIs63MHz) 6204.2, 142.3, 128.1, 127.4, 126.3, 74.3, 54.8, 25.7, 
8.0, -4.6, -5.2. IR (thin film, cm-l): 1782, 1694. [M+Na+]+ calc’d for 
C,,H,,O,SiNa: 301 .1594; found: 301 .1590. 
(4R)-[(2/R, 3’S, 4/R, 5’S)-3’Hydroxy-2: 4’methykT’[(tert- 
bu~ld~methylsi~~)oxy~-phenylpentanoyl~-4-phenylmethyl-2- 
oxazolidinone [4 I] 
Di-n-butylboron triflate (0.43 ml, 1.7 mmol, 1.2 eq) and triethylamine 
(0.27 ml, 1.9 mmol, 1.4) were added dropwise to a stirred solution 
of (4/?)-3-propionyl-4-phenylmethyl-2-oxazolidinone (0.34 g, 1.4 mmol, 
1 .O eq) in dry dichloromethane (20 ml) at 0%. The resulting solution was 
stirred at -78% for 20 min, then (2S, 3S)-3-[(tert-butyldimethylsilyl)oxy)- 
2-methyl-5-phenylpropanal (0.41 g, 1.5 mmol, 1 .l eq) was added. The 
solution was stirred at -78% for 20 min and at O’C for 2 h. The reaction 
was quenched by the addition of pH 7 phosphate buffer (1.9 ml) and 
methanol (71 ml). A 2:l mixture of methanol/hydrogen peroxide (27 wto/, 
in H,O) (5.7 ml) was added dropwise at 0% and the resulting solution 
stirred at 0°C for 1 h. The volatiles were removed in vacua and the slurry 
extracted with diethyl ether (3 x 50 ml). The extracts were washed with 
5% sodium sulphite solution (30 ml), and then extracted with ether 
(50 ml). The combined extracts were dried (MgSO,) and concentrated in 
~racuo. The crude product was purified by flash column chromatography 
(silica gel, 15Yo ethyl acetate in light petroleum) to afford 0.409 
(0.78 mmol, 56%) of (4/?)-[(2’R, 3’S, 4’R, 5’S)-3’-hydroxy-2’, 4’-methyl- 
5’[(tert-butyldimethylsilyl)oxyl-phenylpentanoyll-4-phenylmethyl-2-oxazo- 
lidinone. [ajo=-78’ (c 2.36 CHCI,). ‘H NMR (CDCI, 500 MHz) 
6 7.36-7.19 (m, 1 OH, 2 x Ph-H), 5.24 (d, J = 2.0 Hz, 1 H, C(5’)-H), 4.73 
(m, 1 H, C(4)-H), 4.24-4.08 (m, 2H, C(2’)-H and C(33-H), 3.88 (m, 2H, 
C(5)-H,), 3.28 (dd, J = 13.3, 3.3 Hz, 1 H, one of C(4)-CH,), 2.78 (dd, 
J= 13.3, 9.6 Hz, lH, one of C(4)-CH,), 1.77 (m, lH, C(4’)-H), 1.23 (d, 
J=7.0 Hz, 3H, C(P’)-CH,), 0.93 (s, 9H, t-Bu-H), 0.71 (d, J=7.0 Hz, 
C(4’)-CH,), 0.085 (s, 3H, one of Si-CH,), -0.16 (s, 3H, one of Si-CH,). 
‘% NMR (CDCI, 100 MHz) 6 177.9, 152.8, 143.6, 135.2, 129.5, 
129.0, 127.7, 127.4, 126.7, 126.6, 74.3, 71.8, 66.2, 55.2, 43.5, 39.7, 
37.8, 26.0, 18.3, 9.2, -4.6, -5.2. IR (thin film, cm-l): 3528, 1788, 1680. 
[M+Na+]+ calc’d for C,,H,,O,NSiNa: 534.2646; found: 534.2650. 
(2R, 3S, 4R, 5S)-3, 5-Dihydroxy-2, 4-dimethyl-5phenyl-n- 
pentanoic acid-6lactone 26 [44] 
Hydrogen peroxide (0.35 ml of a 30% solution, 2.8 mmol, 4.6 eq) and 
lithium hydroxide (0.058 g, 1.4 mmol, 2.3 eq) were added to a stirred 
solution (4R)-[(2’R, 3’S, 4’R, 5’S)-3’-hydroxy-2: 4’-methyl-5’[tert- 
butyldimethylsilyl)oxy]-phenylpentanoyl]-4-phenylmethyl-2-oxazolidinone 
(0.31 g, 0.61 mmol, 1 .O eq) in a 3:l mixture of THFlwater (20 ml) at 
0°C. The reaction mixture was stirred at room temperature for 20 min, 
cooled to 0% and quenched with sodium sulphite solution (3.3 ml of a 
1.5 M solution in water, 5.0 mmol, 8.2 eq). The THF was removed in 
vacua and the aqueous solution extracted with dichloromethane 
(3 x 20 ml). The chiral auxiliary was separated from the acid by flash 
column chromatography (10% isopropanol in light petroleum), and the 
resulting acid was stirred at 40°C in a solution of 1 M HCI (10 ml) and 
THF (2 ml) for 4 h. The solution was extracted with ethyl acetate 
(3 x 10 ml), the extracts washed with brine, dried (MgSO,) and the 
solvent removed in vacua to yield 0.060 g (0.25 mmol, 400/b) of (2R, 
3S, 4R, 5s)3, 5-dihydroxy-2, 4-dimethyC5-phenyl-n-pentanoic acid-& 
lactone 26. [o]o = + 8.7“ (c 0.470 CHCI,). ‘H NMR (CDCI, 400 MHz) 
6 7.42-7.25 (m, 5H, Ph-H), 5.42 (d, J = 2.5 Hz, 1 H, C(5)-H), 4.08 (dd, 
J = 10.4, 4.3 Hz, 1 H, C(3)-H), 2.60 (dq, J = 10.4, 7.1 Hz, 1 H, C(2)-H), 
2.43 (qdd, J = 7.1, 4.1, 2.6 Hz, 1 H, C(4)-H), 1.48 (d, J = 7.0 Hz, 3H, 
C(2)-CH,), 0.77 (d, J=7.1 Hz, 3H, C(4)CHs). '3C NMR (CDCI, 
100MHz) 6 173.2, 137.4, 128.4, 127.8, 125.2, 80.2, 74.0, 40.2, 39.8, 
14.3, 4.6. IR (thin film, cm-l): 3480, 1716. [M+Na+]+ calc’d for 
C,,H,,O,Na: 243.0992; found: 243.0985. 
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